These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 4877649

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Clinical research on the antipyretic effects of indomethacin in systemic hemopathies].
    Marcolongo R, Bianco G, Di Paolo N, Bravi A.
    Minerva Med; 1970 Oct 13; 61(82):4532-41. PubMed ID: 5273365
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [Determination of beta 1 C-A (complement factor 3) in malignant lymphoma, myeloma, and Waldenström's disease].
    Meier EC, Grob PJ.
    Dtsch Med Wochenschr; 1972 Jun 23; 97(25):967-71. PubMed ID: 4624059
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. A comparison of paper electrophoretic and immunoelectrophoretic studies of the serum proteins of patients with lymphomas and leukemias.
    Leoncini D, Forni A, Korngold L, Miller DG.
    Oncology; 1968 Jun 23; 22(2):81-117. PubMed ID: 4880062
    [No Abstract] [Full Text] [Related]

  • 27. [Thrombocyte functions in malignant blood diseases].
    Lisichkov T, Avramova D, Dobreva A, Meshkov T, Ignatova E.
    Vutr Boles; 1987 Jun 23; 26(4):74-7. PubMed ID: 3478895
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Properdin level in proliferative diseases of the hematopoietic system].
    Pietruska Z.
    Pol Arch Med Wewn; 1968 Jun 23; 40(6):711-5. PubMed ID: 5244787
    [No Abstract] [Full Text] [Related]

  • 32. [HL-A antigens and malignant hematological diseases].
    Jeannet M, Alberto P, Wyss M.
    Schweiz Med Wochenschr; 1971 Dec 11; 101(49):1798-800. PubMed ID: 5291103
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Hematologic diseases and opsonic alpha 2-macroglobulin. A correlative study].
    Tilz GP.
    Acta Med Austriaca Suppl; 1979 Dec 11; 6():372-5. PubMed ID: 95542
    [Abstract] [Full Text] [Related]

  • 35. [Results of the surgical treatment of patients with hematologic diseases].
    Gaĭbatov SP, Abdulaev MA.
    Vestn Khir Im I I Grek; 1988 Apr 11; 140(4):122-4. PubMed ID: 3166549
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [What is reliable in the therapy of hematologic diseases? I. Hemoblastosis and malignant lymphoproliferative diseases].
    Havemann K, Schmidt M, Malchow H, Sodomann CP.
    Internist (Berl); 1970 Dec 11; 11(12):441-9. PubMed ID: 4993105
    [No Abstract] [Full Text] [Related]

  • 39. The fibrinolytic enzyme system in haematological malignancy.
    Dawson AA, Ogston D, Douglas AS.
    Bibl Anat; 1973 Dec 11; 12():272-8. PubMed ID: 4597632
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.